Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer.
about
Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancerPlasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancerA white-box approach to microarray probe response characterization: the BaFL pipeline.Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancerReduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancerOverexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancerSmall integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancerOsteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis.Osteopontin is a prognostic biomarker in non-small cell lung cancer.Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progressionPrognostic significance of osteopontin in patients with lung cancer: a meta-analysis.Prognostic implications of adhesion molecule expression in colorectal cancerOverexpression of OLC1, cigarette smoke, and human lung tumorigenesis.The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts.Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC).Adaptation of a chemosensitivity assay to accurately assess pemetrexed in ex vivo cultures of lung cancerProteins involved in regulating bone invasion in skull base meningiomas.Integrative analyses identify osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for lung cancer.Elevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer.Correlation between lung neoplasm and serum level of osteopontin: A meta-analysis.Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population.Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003Curcumin Veto the Effects of Osteopontin (OPN) Specific Inhibitor on Leukemic Stem Cell Colony Forming Potential via Promotion of OPN OverexpressionIdentification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.Plasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancer.A double-negative feedback loop between E2F3b and miR- 200b regulates docetaxel chemosensitivity of human lung adenocarcinoma cellsTranscriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis.Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancersMicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity.Clinical Significance of Circulating Osteopontin Levels in Patients With Lung Cancer and Correlation With VEGF and MMP-9.Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysisOPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
P2860
Q30316974-F1DF8939-9FC5-4660-8DBA-D14FE45257F6Q33254071-29AD9C79-ABF7-4332-AC9E-CCFDE310685CQ33317638-02DD65E6-646D-44BA-AD74-DEE569AB502DQ33521107-7BCED000-ACBC-4AD3-A656-C9B9B7F157D7Q33584942-2F33FA0C-3660-4748-B5FA-E78CD6E939CEQ33710746-B3B419C2-B2A1-46CA-A131-C6B41206BF1FQ34017957-5D0DCEC8-81FB-4D50-80BB-1DA123ECA662Q34251088-83BD81F8-3D7C-4BDE-87C8-F26A17F76AA6Q34361505-F7CE7BC6-288C-463F-824E-10B3D5378C1FQ34465282-CEE92604-8018-48B9-8BFE-9301F499DB99Q34655823-9E3002BA-DBF9-415F-880B-D97EC00F4B80Q34839346-EFFBCC5A-4369-47E6-8082-AB66AE43B6DCQ35038432-8CB80A91-8B12-4D35-8F98-DF0D96AAB9ECQ35065341-6AF02296-DD04-421E-BAFA-569C1BE4A0EDQ35257796-4FBD8D3B-6B7D-4FAD-984C-11B06B576163Q35558111-2E1AE340-84AE-47B1-8099-D3C055509F92Q35741189-F4D1B579-175B-4DFD-ADE7-0B3447BDDEF7Q35821113-1D78F5D2-F4BD-45B2-94D0-92A19ADB7799Q35863920-48872D86-76B3-46C3-8447-A65F2F5C519AQ36079101-AB379BF7-6E54-4ACB-B53D-84B2FA338F26Q36359897-F53C3FE7-09C6-4C49-8650-99FA78B663D6Q36563137-99BF05E9-AAC2-489B-8876-DCE6BA884EBEQ36591925-7CBE9BC2-31B0-429E-AB82-EE042F89F6E5Q36602006-BDC90310-457B-49B5-AE00-0BE3884D1022Q36618490-3D6D7239-662B-4E50-A526-7AA9DC8639E4Q36654589-61F5D2C0-237A-4202-BE51-8901B2515FACQ36824788-1D045D1E-E260-4C31-B51F-753537963BF8Q37103777-3C387602-CDCB-4AF5-956E-A374540D6C76Q37121729-C6A3D60C-72FF-4C5F-8361-A75448B61B2AQ37144443-6D63A0DE-D7F2-4C13-BC56-2E11BB904781Q37160321-FDC213AC-C27D-437D-A086-17EDCFB2463FQ37213965-93284CC7-5D77-4922-85E5-5B31606FD8D6Q37317341-13F6AB25-B12E-4946-8BFC-0172ED119518Q37448428-8A254169-D31F-4458-83DB-10AFA3D91F38Q37625382-1B19A59C-04A2-48FD-ADA3-0A8927959DE2Q39433284-5E92D980-CB28-4865-9083-05976290D95BQ39789110-A6F9DF2C-081F-4954-A8C1-1AD14D714E7BQ40582898-DE1F1276-4FA7-4160-B9E5-512D1590D21DQ42003931-7B98A431-18DA-4012-937D-853263C7B4E4Q42200175-16C18FEB-D43C-4EE0-8F79-9F88E1EDC22F
P2860
Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Overexpression of osteopontin ...... an non-small cell lung cancer.
@en
type
label
Overexpression of osteopontin ...... an non-small cell lung cancer.
@en
prefLabel
Overexpression of osteopontin ...... an non-small cell lung cancer.
@en
P2093
P1476
Overexpression of osteopontin ...... an non-small cell lung cancer.
@en
P2093
Dongmei Lin
Husheng Zhang
Jinfang Ma
Jingsong Yuan
Junhang Zhang
Meixia Gao
Naijun Han
Shujun Cheng
Xuebing Di
P304
P356
10.1158/1078-0432.CCR-04-2013
P407
P577
2005-07-01T00:00:00Z